Premavision Cohort Follow-up (PrmvsionSuiv)

Central Hospital, Nancy, France

Status: Terminated

Conditions: Visual Disorder

Treatments: Diagnostic Test: Visual acuity measurement

Study type: Interventional

Funder types: Other

Identifiers

NCT03207477

2016-A02017-44

Details and patient eligibility

About

This study aim at following a cohort of prematurely born infants at 18 months corrected age, 4 and 7 years of age. This cohort had an evaluation of visual maturation at term equivalent age (TEA) with factors associated with impaired visual maturation. (PREMAVISION-CLinicalTrials.gov ID: NCT02890251).

In this follow-up study, prematurely born infants vision will be compared to term born infants matched for postnatal age.

Enrollment: 37 patients

Sex: All

Ages: 18 months to 7 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Infants included in the Premavision cohort
• Term born healthy control infants at matched postnatal age

Exclusion criteria

• Ocular malformation
• Genetic abnormality
• Neurodevelopmental impairment

Trial design

Primary purpose: Screening

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

37 participants in 2 patient groups

Prematurely born infants

Experimental group

Description:

Visual acuity measurement in prematurely born infants included in PREMAVISION study

Treatment:

Diagnostic Test: Visual acuity measurement

Term born infants

Active Comparator group

Description:

Visual acuity measurement in term born control infants

Treatment:

Diagnostic Test: Visual acuity measurement